Chronic levodopa treatment alters expression and function of dopamine D3 receptor in the MPTP/p mouse model of Parkinson’s disease

Bezard, 2003, Attenuation of levodopa-induced dyskinesia by normalizing dopamine D3 receptor function, Nat. Med., 9, 762, 10.1038/nm875 Bordet, 2000, Involvement of the direct striatonigral pathway in levodopa-induced sensitization in 6-hydroxydopamine-lesioned rats, Eur. J. Neurosci., 12, 2117, 10.1046/j.1460-9568.2000.00089.x Guigoni, 2005, Pathogenesis of levodopa-induced dyskinesia: focus on D1 and D3 dopamine receptors, Parkinsonism Relat. Disord., 11, S25, 10.1016/j.parkreldis.2004.11.005 Sun, 2013, Regulation of dopamine D3 receptor in the striatal regions and substantia nigra in diffuse Lewy body disease, Neuroscience, 248C, 112, 10.1016/j.neuroscience.2013.05.048 Mahmoudi, 2014, Upregulation of dopamine D3, not D2, receptors correlates with tardive dyskinesia in a primate model, Mov. Disord., 9, 1125, 10.1002/mds.25909 Gross, 2003, Pattern of levodopa-induced striatal changes is different in normal and MPTP-lesioned mice, J. Neurochem., 84, 1246, 10.1046/j.1471-4159.2003.01600.x Cote, 2014, Overexpression of the dopamine D3 receptor in the rat dorsal striatum induces dyskinetic behaviors, Behav. Brain Res., 263, 46, 10.1016/j.bbr.2014.01.011 van Kampen, 2003, Effects of oligonucleotide antisense to dopamine D3 receptor mRNA in a rodent model of behavioural sensitization to levodopa, Neuroscience, 116, 307, 10.1016/S0306-4522(02)00548-1 Sánchez-Pernaute, 2007, In vivo evidence of D3 dopamine receptor sensitization in parkinsonian primates and rodents with l-DOPA-induced dyskinesias, Neurobiol. Dis., 27, 220, 10.1016/j.nbd.2007.04.016 Visanji, 2009, Dopamine D3 receptor stimulation underlies the development of l-DOPA-induced dyskinesia in animal models of Parkinson’s disease, Neurobiol. Dis., 35, 184, 10.1016/j.nbd.2008.11.010 Cote, 2014, In vitro and in vivo characterization of the agonist-dependent D3 dopamine receptor tolerance property, Neuropharmacology, 79, 359, 10.1016/j.neuropharm.2013.11.023 Petroske, 2001, Mouse model of Parkinsonism: a comparison between sub acute MPTP and chronic MPTP/probenecid treatment, Neuroscience, 106, 589, 10.1016/S0306-4522(01)00295-0 Meredith, 2008, Modeling PD pathogenesis in mice: advantages of a chronic MPTP protocol, Parkinsonism Relat. Disord., 14, S112, 10.1016/j.parkreldis.2008.04.012 Schintu, 2009, Progressive dopaminergic degeneration in the chronic MPTPp mouse model of Parkinson’s disease, Neurotox. Res., 16, 127, 10.1007/s12640-009-9061-x Li, 2012, Molecular characterization of individual D3 dopamine receptor-expressing cells isolated from multiple brain regions of a novel mouse model, Brain Struct. Funct., 217, 809, 10.1007/s00429-012-0383-8 Pasuit, 2004, Multi-modal regulation of endogenous D1 dopamine receptor expression and function in the CAD catecholaminergic cell line, J. Neurochem., 89, 1508, 10.1111/j.1471-4159.2004.02450.x Meredith, 2009, Impaired glutamate homeostasis and programmed cell death in a chronic MPTP mouse model of Parkinson's disease, Exp. Neurol., 219, 334, 10.1016/j.expneurol.2009.06.005 Valjent, 2005, Regulation of a protein phosphatase cascade allows convergent dopamine and glutamate signals to activate ERK in the striatum, Proc. Nat. Acad. Sci. U. S. A., 102, 491, 10.1073/pnas.0408305102 Santini, 2007, Critical involvement of cAMP/DARPP-32 and extracellular signal-regulated protein kinase signaling in l-DOPA-induced dyskinesia, J. Neurosci., 27, 6995, 10.1523/JNEUROSCI.0852-07.2007 Sokoloff, 2013, Direct and indirect interactions of the dopamine D3 receptor with glutamate pathways: implications for the treatment of schizophrenia, Naunyn Schmiedebergs Arch. Pharmacol., 386, 107, 10.1007/s00210-012-0797-0 Holmer, 2005, l-dopa-induced reversal in striatal glutamate following partial depletion of nigrostriatal dopamine with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, Neuroscience, 136, 333, 10.1016/j.neuroscience.2005.08.003 Liu, 2009, Activity-dependent modulation of limbic dopamine D3 receptors by CaMKII, Neuron, 61, 425, 10.1016/j.neuron.2008.12.015 Brown, 2005, Dopamine depletion alters phosphorylation of striatal proteins in a model of Parkinsonism, Eur. J. Neurosci., 22, 247, 10.1111/j.1460-9568.2005.04190.x